Akademisyen
CENGİZ ERMİŞ
PROFESÖR
AKDENİZ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Kardiyoloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 39
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
23
Q2
1
Q3
2
Q4
0
WoS (JCR)
Q1
13
Q2
4
Q3
5
Q4
5
TR Index
1
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
5
Ort. yüzdelik
82.5%
Üst %1 payı
0.0%
Üst %10 payı
25.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2022 Evaluation of atrial electromechanical functions in dipper and nondipper hypertension patients using left atrial strain P-wave dispersion and P terminal force YÖKSİS SJR Q3 JCR Q4
- 2017 Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves YÖKSİS SJR Q1 JCR Q1
- 2017 Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 Trial YÖKSİS SJR Q1 JCR Q2
- 2017 Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48) YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.9%
- 2016 Red cell distribution width and neutrophil-to-lymphocyte ratio predict left ventricular dysfunction in acute anterior ST-segment elevation myocardial infarction YÖKSİS SJR Q3 JCR Q4 OpenAlex 85.6%
- 2016 Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48) YÖKSİS SJR Q1 JCR Q1
- 2016 Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48 YÖKSİS SJR Q1 JCR Q2
- 2014 Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 YÖKSİS SJR Q1 JCR Q1
- 2013 Edoxaban versus Warfarin in Patients with Atrial Fibrillation YÖKSİS SJR Q1 JCR Q1
- 2012 Evaluation of the left ventricular regional function using two-dimensional speckle tracking echocardiography in patients with end-stage renal disease with preserved left ventricular ejection fraction YÖKSİS
- 2012 The significance of the left atrial volume index in cardioversion success and its relationship with recurrence in patients with non-valvular atrial fibrillation subjected to electrical cardioversion: a study on diagnostic accuracy YÖKSİS TR Index JCR Q4 OpenAlex 85.2%
- 2009 Relationship of Paroxysmal Atrial Tachyarrhythmias to Volume Overload: Assessment by Implanted Transpulmonary Impedance Monitoring YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 91.0%
- 2009 Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in peritoneal dialysis patients YÖKSİS SJR Q2 JCR Q4 OpenAlex 78.7%
- 2008 Ruptured Aneurysm of Noncoronary Sinus of Valsalva: Demonstration with Magnetic Resonance Imaging YÖKSİS SJR Q1 JCR Q4 OpenAlex 69.6%
- 2008 Oxidative Stress and Asymmetric Dimethylarginine Is Independently Associated with Carotid Intima Media Thickness in Peritoneal Dialysis Patients YÖKSİS SJR Q1 JCR Q1 OpenAlex 82.2%
- 2008 Association of increased QTc dispersion and right ventricular hypertrophy YÖKSİS
- 2007 Reduced Atrial Tachyarrhythmia Susceptibility After Upgrade of Conventional Implanted Pulse Generator to Cardiac Resynchronization Therapy in Patients With Heart Failure YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.3%
- 2007 Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients = 75 years of age treated with implantable cardioverter defibrillators YÖKSİS SJR Q1 JCR Q3 OpenAlex 80.4%
- 2006 Cardiac resynchronization pacing without defibrillator capability: is this a viable option? YÖKSİS SJR Q1 JCR Q3 OpenAlex 68.2%
- 2005 Impact of Upgrade to Cardiac Resynchronization Therapy on Ventricular Arrhythmia Frequency in Patients With Implantable Cardioverter-Defibrillators YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.8%